CN113388527B - A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 - Google Patents
A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 Download PDFInfo
- Publication number
- CN113388527B CN113388527B CN202110649166.6A CN202110649166A CN113388527B CN 113388527 B CN113388527 B CN 113388527B CN 202110649166 A CN202110649166 A CN 202110649166A CN 113388527 B CN113388527 B CN 113388527B
- Authority
- CN
- China
- Prior art keywords
- physcion
- strain
- yield
- aspergillus
- byst1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 title claims abstract description 77
- UGNZSMZSJYOGNX-UHFFFAOYSA-N Isoviocristine Natural products O=C1C=C(C)C(=O)C2=CC3=CC(OC)=CC(O)=C3C(O)=C21 UGNZSMZSJYOGNX-UHFFFAOYSA-N 0.000 title claims abstract description 38
- WLXGUTUUWXVZNM-UHFFFAOYSA-N anthraglycoside A Natural products C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1OC1OC(CO)C(O)C(O)C1O WLXGUTUUWXVZNM-UHFFFAOYSA-N 0.000 title claims abstract description 38
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 title claims abstract description 38
- 241001065417 Aspergillus chevalieri Species 0.000 title claims description 15
- 241000122821 Aspergillus kawachii Species 0.000 title claims description 4
- 239000001963 growth medium Substances 0.000 claims abstract description 28
- 238000000855 fermentation Methods 0.000 claims abstract description 20
- 230000004151 fermentation Effects 0.000 claims abstract description 20
- 239000007788 liquid Substances 0.000 claims abstract description 18
- 238000004321 preservation Methods 0.000 claims abstract description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 12
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 9
- 239000000287 crude extract Substances 0.000 claims description 7
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 6
- 238000009630 liquid culture Methods 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 239000003208 petroleum Substances 0.000 claims description 6
- 238000010828 elution Methods 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 238000004519 manufacturing process Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000000741 silica gel Substances 0.000 claims description 3
- 229910002027 silica gel Inorganic materials 0.000 claims description 3
- 238000005481 NMR spectroscopy Methods 0.000 claims description 2
- 241001513093 Aspergillus awamori Species 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 238000011049 filling Methods 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 238000011068 loading method Methods 0.000 claims 1
- 238000001819 mass spectrum Methods 0.000 claims 1
- 238000004458 analytical method Methods 0.000 abstract description 3
- 241000228212 Aspergillus Species 0.000 abstract description 2
- 239000007791 liquid phase Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000002609 medium Substances 0.000 description 8
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 7
- 239000008103 glucose Substances 0.000 description 7
- 241000866536 Odontotermes formosanus Species 0.000 description 6
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 241000233866 Fungi Species 0.000 description 4
- 244000061456 Solanum tuberosum Species 0.000 description 4
- 235000002595 Solanum tuberosum Nutrition 0.000 description 4
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 3
- 229910052564 epsomite Inorganic materials 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 239000002207 metabolite Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 229960004793 sucrose Drugs 0.000 description 3
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 2
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000221785 Erysiphales Species 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 229910052603 melanterite Inorganic materials 0.000 description 2
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000012086 standard solution Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- FFRBMBIXVSCUFS-UHFFFAOYSA-N 2,4-dinitro-1-naphthol Chemical group C1=CC=C2C(O)=C([N+]([O-])=O)C=C([N+]([O-])=O)C2=C1 FFRBMBIXVSCUFS-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 108091023242 Internal transcribed spacer Proteins 0.000 description 1
- 241000256602 Isoptera Species 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 241000233679 Peronosporaceae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 244000000005 bacterial plant pathogen Species 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 229910052956 cinnabar Inorganic materials 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000002888 effect on disease Effects 0.000 description 1
- 238000003810 ethyl acetate extraction Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000006799 invasive growth in response to glucose limitation Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 235000012015 potatoes Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/06—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing keto or thioketo groups as part of a ring, e.g. cyclohexanone, quinone; Derivatives thereof, e.g. ketals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/24—Preparation of oxygen-containing organic compounds containing a carbonyl group
- C12P7/26—Ketones
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Environmental Sciences (AREA)
- Plant Pathology (AREA)
- General Chemical & Material Sciences (AREA)
- Agronomy & Crop Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dentistry (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
The invention discloses a physcion high-yield strain, and simultaneously provides an acquisition mode of the strain and a physcion yield analysis method, the physcion high-yield strain provided by the invention is Aspergillus chevalieriBYST1, the preservation unit is China center for type culture Collection, the preservation number is CCTCC2021285, and the preservation date is 26 months at 3 months in 2021. The invention provides an obtaining mode of the strain and the yield analysis of physcion, which mainly comprises the following steps: (1) separating and purifying the strain; (2) fermenting, separating and identifying the main component physcion; (3) liquid phase quantifying the yield of physcion; (4) nine different culture mediums are used for shake flask fermentation to evaluate the yield difference of the physcion. The strain is fermented in a liquid PDB culture medium, the yield of physcion is 28mg/L, and the current report shows the highest yield.
Description
Technical Field
The invention belongs to the technical field of biology, and provides an physcion high-yield strain.
Background
Physcion, also known as cinnabar B; a non-ketonic group; 1, 8-dihydroxy-3-methoxy-6-methylanthraquinone is golden yellow needle crystal. The physcion can inhibit the germination and growth of fungi and can induce crops to generate anti-stress defense reaction; the bactericidal composition has excellent control effect on powdery mildew of most crops, and also has better control effect on downy mildew, gray mold, anthracnose and the like; the physcion has extremely low toxicity to human and livestock, is environment-friendly, and is particularly suitable for biological preparations produced by green and organic vegetables.
At present, physcion is autonomously developed into a novel plant source bactericide by China, has huge effect on disease control and good market economic benefit, but the method deviates from the green economic concept, has large demand on plants, more residues and generally lower yield, and the main raw material glucose of the microbial fermentation method belongs to renewable resources, so the cost is lower and the product yield is higher.
Disclosure of Invention
The invention provides a physcion high-yield strain named Aspergillus chevalieri BYST1 aiming at the technical defects, and the preservation unit is as follows: china Center for Type Culture Collection (CCTCC); and (4) storage address: wuhan university in Wuhan, China; the preservation date is as follows: 26 months 3 in 2021; the preservation number is as follows: CCTCC M2021285. The strain is symbiotic bacteria of odontotermes formosanus, the yield of the physcion produced by shaking flask fermentation is 28mg/L, and the strain has important significance for the production of pesticide after the day.
Insect symbiotic bacteria are a special class of microorganisms and are a source of many new active natural products. The invention relates to a method for preparing physcion from Aspergillus chevalieri BYST1 strain separated from odontotermes formosanus, which comprises the following steps:
(1) preparation of BYST1 strain fermentation liquor: the strain BYST1 is inoculated in an ME (raw malt 20g, cane sugar 20g, peptone 1g, 1000mL water) liquid culture medium, and the seed liquid obtained after 3d of shaking culture is inoculated in other culture media for mass fermentation for 7d to obtain fermentation liquid under the conditions of 28 ℃ and 180 r/min.
(2) Separation and purification of metabolites: concentrating the organic layer of fermentation liquor of Aspergillus chevalieri BYST1 strain after ethyl acetate extraction under reduced pressure to obtain crude extract. And performing gradient elution by using dichloromethane and methanol at the volume ratio of 100:0, 100:1, 100:2, 100:4 and 100:8 as a mobile phase, and combining the analysis results of the same components to obtain four components Fr1-Fr 4. Fr1 was repacked on a silica gel column and graded with a petroleum ether/ethyl acetate system, petroleum ether: ethyl acetate eluted at 5:1(v/v) to give Compound A1(320 mg).
(3) Identification of metabolites: using mass spectrometry (ESI-MS) and nuclear magnetic resonance (ESI-MS)1H-NMR、13C-NMR) to identify the structure of the compound A1, and determining that the compound is physcion, wherein the structure is as follows:
after the fermentation medium is further screened, the yield of the physcion can reach 28mg/L, which is the highest reported at present.
In conclusion, the invention obtains the high-yield physcion strain Aspergillus chevalieri BYST1, and the yield of physcion reaches 28mg/L by using a shake flask experiment, which is the highest reported at present. In view of the excellent effect of preventing and treating powdery mildew and other plant pathogenic bacteria, the physcion has good application value, and especially has the potential of developing into high-yield physcion microorganism chassis cells.
Description of the drawings:
FIG. 1 is a chemical structural formula of physcion which is a main product of fermentation of Aspergillus chevalieri BYST1 provided by an embodiment of the invention.
FIG. 2 shows the colony morphology of the strain Aspergillus chevalieri BYST1 provided in the examples of the present invention.
FIG. 3 is a HPLC check chart of fermentation products of strains provided by examples of the present invention in liquid PDB medium.
FIG. 4 is a graph of the standard curve of physcion established by HPLC as provided in the examples of the present invention.
FIG. 5 is a bar graph of the production of physcion by the strains provided by the examples of the present invention in different liquid media.
Detailed Description
The invention is further explained below with reference to specific embodiments.
Example 1 isolation, purification and characterization of symbiotic species of odontotermes formosanus masst 1(Aspergillus chevalieri BYST 1):
the black-wing odontotermes formosanus adopted from Lanxi Zhejiang, from newly excavated termite nest, taking out soldier ants (20) with sterile forceps, placing in a sterile centrifuge tube, adding 1mL of sterile PBS buffer solution with pH of 7.4, and shaking to obtain rinsing liquid; diluting with sterile water to 10-1、10-2、10-3Three concentration gradients. 0.2mL of each concentration gradient diluent is respectively taken and coated on a PDA solid culture medium, and inverted culture is carried out in a thermostat at 28 ℃. After the colony grows out, picking a small amount of spores from the edge of the colony, transferring the spores to a new PDA culture medium, repeating the transfer to obtain a single colony, and storing the single colony BYST1 to a high-gradient test tube for later use.
Extracting the genome DNA of the sample by using a fungus genome DNA kit, and performing PCR amplification by using a fungus universal primer ITS1 sequence. And the PCR product was sequenced by Shanghai Bioengineering technology services, Inc. The obtained sequence was analyzed by NCBI data nucleotide blast tool alignment to identify the strain as Aspergillus chevalieri.
The PDA culture medium comprises the following components: peeling and chopping 200g of potatoes, boiling to obtain potato juice, adding 20g of glucose, adding 15-20 g of agar, adding water to 1000mL, standing at 121 ℃, and sterilizing for 20 min. Transferring the fungus Aspergillus chevalieri to a PDA slant test tube for standby. The fungus BYST1 is preserved by the following culture collection unit: china Center for Type Culture Collection (CCTCC); and (4) storage address: wuhan university in Wuhan, China; the preservation date is as follows: 26 months 3 in 2021; the preservation number is as follows: CCTCC M2021285.
Example 2 liquid fermentation and activation of the symbiotic fungus Aspergillus chevalieri BYST1 of odontotermes formosanus: the strain Aspergillus chevalieri BYST1 prepared according to the method of example 1 is inoculated into malt liquid culture medium (20.0 g/L of raw malt, 20.0g/L of cane sugar, 1.0g/L of peptone and 1000mL) after being cultured for four days, seed liquid is prepared after being cultured for three days at constant temperature and constant speed (28 ℃ and 180rpm) of a shaking table, the seed liquid is inoculated into 9 different culture media, the culture media are cultured for 7 days at 28 ℃ and 180r/min of shaking table, the collected fermentation liquid is extracted by ethyl acetate in equal volume for three times, and then the organic layer is concentrated under reduced pressure to obtain 10g of crude extract.
Example 3 isolation and purification of metabolite of the symbiotic fungus Aspergillus chevalieri BYST1 of odontotermes formosanus: the crude extract prepared as described in example 2 was loaded dry, packed wet into a column, subjected to gradient elution with dichloromethane/methanol in volume ratios of (100:0, 100:1, 100:2, 100:4, 100:8) in order to obtain four different fractions Fr1-Fr4, and Fr1 was reloaded into a silica gel column, sequentially loaded with petroleum ether: gradient elution of ethyl acetate system, petroleum ether: ethyl acetate 5:1(v/v) gave a yellow powder, which was designated A1. And finally, carrying out structure identification on the compound by combining a plurality of spectrum technologies, and finally determining that A1 is physcion, wherein the spectrum data are as follows:
compound a1 (physcion): orange needle crystals in chloroform, ESI-MS M/z 285.0760[ M + H ]]+The molecular formula is presumed to be C16H12O5。1H-NMR(CDCl3):δH 2.45(3H,s,3-CH3),3.94(3H,s,6-OCH3),6.68 (1H,d,J=2.5Hz,H-7),7.07(1H,d,J=1.0Hz,H-2),7.35(1H,d,J=2.6Hz,H-5),7.61(1H,d, J=1.0Hz,H-4),12.10(1H,s,-OH),12.30(1H,s,-OH);13C-NMR(CDCl3)δC165.42(C-8), 108.40(C-5),162.73(C-1),107.00(C-7),121.48(C-4),148.64(C-3),124.70(C-2),166.77(C-6), 191.00(C-9),182.18(C-10),135.49(C-4a),110.49(C-8a),113.91(C-9a),133.44(C-10a),22.36 (-CH3),56.29(-OCH3)。
Example 4: yield optimization of physcion
The seed liquid obtained by the culture is subjected to high performance liquid chromatography to respectively examine the fermentation capacity of 9 liquid culture media (potato culture medium, malt culture medium, SDB, oat culture medium, Chashi culture medium, Gauss No. 1 culture medium, Takashio culture medium, YPB culture medium and seed culture medium).
(1) The formulation of the nine media was as follows:
PDB: potato, 200.0 g/L; glucose, 20.0 g/L; 1000mL of water.
ME culture medium, raw malt, 20.0 g/L; sucrose, 20.0 g/L; peptone, 1.0 g/L; 1000mL of water.
SDB medium is peptone, 10.0 g/L; glucose, 40.0 g/L; 1000mL of water.
Oat culture medium (OA) of pure oat, 30.0 g/L; 1000mL of water.
Chase Medium (CZB): NaNO3,3.0g/L;KH2PO4,1.0g/L;MgSO4·7H2O,0.5g/L;KCL, 0.5g/L;FeSO4·7H2O,0.01 g/L; glucose, 30.0 g/L; 1000mL of water.
Gao 1 medium (GA 1): soluble starch, 20.0 g/L; NaCl,0.5 g/L; KNO3,1.0g/L; K2HPO4·3H2O,0.5g/L;MgSO4·7H 20,0.5g/L;FeSO4·7H2O,0.01 g/L; 1000mL of water.
Takashio medium: KH (Perkin Elmer)2PO4,1.0g/L;MgSO4·7H2O,1.0 g/L; glucose, 20 g/L; tryptone, 1.0 g/L; 1000mL of water.
YPB medium: yeast extract, 1.0 g/L; KH (Perkin Elmer)2PO4,6.0g/L;NaH2PO4,4.0g/L;NH4OH,1.0 g/L; 1000mL of water.
Seed medium (ZZB): glucose, 60.0 g/L; peptone, 20.0 g/L; KH (Perkin Elmer)2PO4,2.0g/L; MgSO4·7H2O,1.0 g/L; 1000mL of water.
(2) Preparation of an physcion standard solution: the physcion was accurately weighed and sequentially prepared as a gradient standard solution of 250/8,250/5,250/4,250/3,250/2,250. mu.g/mL.
(3) Chromatographic conditions are as follows: thermo Scientific U3000; column ZORBAX Eclipse Plus C18 Rapid Resolution HD 2.1 x 100mm 1.8-micro; UV 254; eluting with a mobile phase of methanol and 1% acetic acid water solution at a volume ratio of 85:15 for 20 min; the flow rate was 0.2 mL/min.
(4) Drawing a standard curve: drawing a standard curve shown in figure 4 according to the relationship between the peak area and the concentration of the standard substance(y=0.3322x,R2=0.9999)。
(5) Treatment of the test samples: inoculating the activated BYST-1 thalli into a seed culture medium, preparing a seed solution, inoculating the seed solution into the 9 culture media in an inoculation amount of 1:10, inoculating 3 bottles of each culture medium, and then placing the culture medium at 28 ℃; shaking the shaking table at constant temperature, fermenting for 7 days, extracting 9 kinds of fermentation broth with different culture media with ethyl acetate for 4 times, mixing ethyl acetate layers, concentrating, evaporating to dryness to obtain crude extract, dissolving with methanol completely, and recording the volume of the solution. And calculating the content of the physcion in the fermentation liquid of different culture mediums by using a standard curve.
The results show that: in the fermentation liquid of nine kinds of test liquid culture mediums, except that physcion can not be detected in the fermentation liquid of oat culture medium, physcion can be detected in other 8 kinds of culture mediums (as shown in figure 5), wherein the yield of PDB, ME and SDB is above 15mg/L, and the yield in the fermentation liquid of PDB is the highest and reaches 28.0 mg/L.
Finally, it is to be noted that the above-mentioned list is only a few specific embodiments of the present invention. It is obvious that the invention is not limited to the above embodiments, but that many variations are possible. All modifications (especially the construction of the high-yield physcion-producing microbial underpan cells from the bacterium) which can be directly derived or suggested by one of ordinary skill in the art from the present disclosure are to be considered as the protection scope of the present invention.
Claims (2)
1. Symbiotic fungi Aspergillus awamori (Aspergillus chevalieri) BYST1, the strain is preserved in China Center for Type Culture Collection (CCTCC) at 26 months 3 and 2021, and the preservation number of the strain is CCTCC M2021285.
2. Use of the aspergillus kawachii (a) as claimed in claim 1Aspergillus chevalieri) The method for producing physcion by BYST1 is characterized by comprising the following steps:
1) the strain Aspergillus kawachii cultured for four days is addedAspergillus chevalieri) BYST1 is inoculated in malt liquid culture medium, the shaking table is kept at constant temperature and constant speed of 28 ℃ and at constant speed of 180rpm, and the culture is carried out for three days to obtain the productSeed liquid;
2) inoculating the seed liquid into a PDB and ME liquid culture medium, culturing at 28 ℃ for 180r/min in a shaking table for 7d to obtain a fermentation liquid;
3) filtering the fermentation liquor obtained in the step 2), extracting the filtrate with ethyl acetate, and performing vacuum concentration and drying to obtain a crude extract;
4) loading the crude extract obtained in the step 3) by a dry method, filling the crude extract into a column by a wet method, and performing gradient elution by adopting dichloromethane/methanol, wherein the volume ratio of the two is 100:0, 100:1, 100:2, 100:4 and 100:8 in sequence to obtain four different components Fr1-Fr 4;
5) the 3 rd eluate fraction Fr1 obtained was repacked on a silica gel column and successively purified by passing through petroleum ether: gradient elution of ethyl acetate system, petroleum ether: eluting with ethyl acetate 5:1(v/v) to obtain a brown powder, and identifying the structure of the brown powder by mass spectrum and nuclear magnetic resonance to determine that the compound is physcion, and the structural formula is as follows:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110649166.6A CN113388527B (en) | 2021-06-10 | 2021-06-10 | A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110649166.6A CN113388527B (en) | 2021-06-10 | 2021-06-10 | A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113388527A CN113388527A (en) | 2021-09-14 |
CN113388527B true CN113388527B (en) | 2022-03-29 |
Family
ID=77620292
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110649166.6A Active CN113388527B (en) | 2021-06-10 | 2021-06-10 | A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113388527B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114276966B (en) * | 2022-01-07 | 2023-07-25 | 黑龙江龙九堂药业有限公司 | Astragalus endophytic bacterium for producing isoflavone component and application thereof |
CN115261235B (en) * | 2022-05-23 | 2023-07-25 | 浙江工业大学 | Aspergillus terreus F6-3 and application thereof in preparation of 6-hydroxy aloe-emodin-8-methyl ether |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002081483A2 (en) * | 2001-04-06 | 2002-10-17 | The Regents Of The University Of California | Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
CN104946693A (en) * | 2015-07-23 | 2015-09-30 | 江苏省海洋资源开发研究院(连云港) | Method for preparing questin by utilizing ocean aspergillus flavipes HN4-13 bacterial strain and application of questin |
CN110964649A (en) * | 2019-12-11 | 2020-04-07 | 中国科学院青岛生物能源与过程研究所 | Engineering strain for accumulating emodin-8-methyl ether and construction method and application thereof |
CN112830949A (en) * | 2019-11-22 | 2021-05-25 | 中国医学科学院医药生物技术研究所 | Antifungal compound produced by marine aspergillus and preparation method thereof |
-
2021
- 2021-06-10 CN CN202110649166.6A patent/CN113388527B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002081483A2 (en) * | 2001-04-06 | 2002-10-17 | The Regents Of The University Of California | Inhibitors of acyl glucosaminyl inositol amidase and methods of use |
CN104946693A (en) * | 2015-07-23 | 2015-09-30 | 江苏省海洋资源开发研究院(连云港) | Method for preparing questin by utilizing ocean aspergillus flavipes HN4-13 bacterial strain and application of questin |
CN112830949A (en) * | 2019-11-22 | 2021-05-25 | 中国医学科学院医药生物技术研究所 | Antifungal compound produced by marine aspergillus and preparation method thereof |
CN110964649A (en) * | 2019-12-11 | 2020-04-07 | 中国科学院青岛生物能源与过程研究所 | Engineering strain for accumulating emodin-8-methyl ether and construction method and application thereof |
Non-Patent Citations (3)
Title |
---|
"Fungal secondary metabolite analysis applied to Cultural Heritage: the case of a contaminated library in Venice";A. Micheluz et al.;《World Mycotoxin Journal》;20161231;第9卷(第3期);第397-407页 * |
"ISOLATION, IDENTIFICATION AND BIOACTIVITY SCREENING OF TURKISH MARINE-DERIVED FUNGI";HAJAR HEYDARI et al.;《FARMACIA》;20191231;第67卷(第5期);第780-788页 * |
"海洋真菌Aspergillus sydowii MNP12010103次级代谢产物的研究";王鸿等;《广西大学学报:自然科学版》;20140630;第39卷(第3期);第455-460页 * |
Also Published As
Publication number | Publication date |
---|---|
CN113388527A (en) | 2021-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113388527B (en) | A strain of high-yield physcion Aspergillus kawachii (Aspergillus chevalieri) BYST1 | |
CN104450580B (en) | Preparation method and application of actinomycin D | |
CN111454869B (en) | Marine streptomyces and application thereof | |
CN103740606A (en) | Streptomyces phytohabitans, method for producing new antibiotics Novonestmycin from Streptomyces phytohabitans, and application of Novonestmycin | |
CN113789267B (en) | Aspergillus terreus M7 with antibacterial effect from ocean source and separation and application of secondary metabolite thereof | |
CN110863021A (en) | Preparation method and application of cytochalasin compound | |
CN112795609B (en) | Method for efficiently preparing cyclodepsipeptide, cyclodepsipeptide and application | |
CN114317361A (en) | Streptomyces new strain and separation method and application thereof | |
CN113005048A (en) | Streptomyces nigricans CYS22, metabolite thereof and application thereof | |
CN107488594B (en) | New penicillium and metabolite antacid A thereof | |
CN110527632B (en) | Endophytic fungus strain for efficiently biotransformation of betulinic acid and application thereof | |
CN110964646B (en) | Sclerotinia sclerotiorum, application, fermentation medium and preparation method of PF1022A | |
CN111011388B (en) | Application of dimethyl flavopenicillin in resisting plant pathogenic fungi | |
CN110922974B (en) | Application of mucor circinelloides in degradation of lambda-cyhalothrin | |
CN110092758B (en) | Novel alkaloid compound and wart spore strain for preparing compound by fermentation | |
CN111394277A (en) | Bacterial strain for preparing rapamycin derivative through microbial transformation and application of bacterial strain | |
CN103805543A (en) | Bacterial strain for producing herbimycin and application of bacterial strain | |
CN114292193B (en) | Depsipeptide cyclic ether compound, bacterial strain, preparation method and application | |
CN118063425B (en) | Fusarium oxysporum-resistant active sesquiterpene penicilliuene A and preparation method and application thereof | |
CN115287236B (en) | Preparation method and application of alkaloid compounds derived from insect symbiotic actinomycetes | |
CN116004750B (en) | Method for producing angustin by using erwinia persicae | |
CN116179359B (en) | Marine penicillium pi and its culture method and application | |
CN114836352B (en) | Plant rhizosphere growth-promoting strain F13 and application thereof | |
CN117510441B (en) | Ketone compound penlactone A with plant pathogen resisting activity and preparation method thereof | |
CN113151000B (en) | Marine fungus and application thereof in production of dibutyl phthalate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |